Epigenetic regulation in cancer progression

E Baxter, K Windloch, F Gannon, JS Lee - Cell & bioscience, 2014 - Springer
Cancer is a disease arising from both genetic and epigenetic modifications of DNA that
contribute to changes in gene expression in the cell. Genetic modifications include loss or …

Epigenetics of cervical cancer. An overview and therapeutic perspectives

A Dueñas-González, M Lizano, M Candelaria, L Cetina… - Molecular cancer, 2005 - Springer
Cervical cancer remains one of the greatest killers of women worldwide. It is difficult to
foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic …

Cancer genetics of epigenetic genes

A Miremadi, MZ Oestergaard… - Human molecular …, 2007 - academic.oup.com
The cancer epigenome is characterised by specific DNA methylation and chromatin
modification patterns. The proteins that mediate these changes are encoded by the …

Loss of histone h4k20 trimethylation occurs in preneoplasia and influences prognosis of non–small cell lung cancer

A Van Den Broeck, E Brambilla, D Moro-Sibilot… - Clinical cancer …, 2008 - AACR
Purpose: Epigenetic modifications of histone have crucial roles in the control of gene activity,
nuclear architecture, and genomic stability. In this respect, they may contribute to the …

Differential expression of selected histone modifier genes in human solid cancers

H Özdağ, AE Teschendorff, AA Ahmed, SJ Hyland… - BMC genomics, 2006 - Springer
Background Post-translational modification of histones resulting in chromatin remodelling
plays a key role in the regulation of gene expression. Here we report characteristic patterns …

The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer

T Ezponda, R Popovic, MY Shah, E Martinez-Garcia… - Oncogene, 2013 - nature.com
Epigenetic deregulation of gene expression has a role in the initiation and progression of
prostate cancer (PCa). The histone methyltransferase MMSET/WHSC1 (Multiple Myeloma …

Oncometabolites: tailoring our genes

S Nowicki, E Gottlieb - The FEBS journal, 2015 - Wiley Online Library
Increased glucose metabolism in cancer cells is a phenomenon that has been known for
over 90 years, allowing maximal cell growth through faster ATP production and redistribution …

Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness

A Nguyen, M Yoshida, H Goodarzi… - Nature communications, 2016 - nature.com
Individual cells within a tumour can exhibit distinct genetic and molecular features. The
impact of such diversification on metastatic potential is unknown. Here we identify clonal …

Epigenetics in ovarian cancer: premise, properties, and perspectives

Q Yang, Y Yang, N Zhou, K Tang, WB Lau, B Lau… - Molecular cancer, 2018 - Springer
Malignant ovarian tumors bear the highest mortality rate among all gynecological cancers.
Both late tumor diagnosis and tolerance to available chemical therapy increase patient …

Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes

F Miao, DD Smith, L Zhang, A Min, W Feng… - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—The complexity of interactions between genes and the environment is a major
challenge for type 1 diabetes studies. Nuclear chromatin is the interface between genetics …